Biogen

Biogen Inc.
FormerlyBiogen Idec Inc. (2003–2015)
Company typePublic
IndustryBiotechnology
Founded1978 (1978)
Founders
HeadquartersCambridge, Massachusetts, U.S.
Key people
Products
RevenueDecrease US$9.836 billion (2023)
Decrease US$1.297 billion (2023)
Decrease US$1.162 billion (2023)
Total assetsIncrease US$26.84 billion (2023)
Total equityIncrease US$14.80 billion (2023)
Number of employees
7,570 (2023)
Websitebiogen.com
Footnotes / references
[1]

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.[2]

  1. ^ "Biogen, Inc. 2023 Annual Report". U.S. Securities and Exchange Commission. February 14, 2024.
  2. ^ "Biogen Inc". Bloomberg.